文献速递肺结节与肺癌

医疗保健差异对肺癌筛查与治疗的影响

The Impact of Health Care Disparities on Lung Cancer Screening and Treatment.
PubMed 文献 · Chest · 2025-05-09

本文为叙述性综述,探讨美国及全球范围内种族、民族、年龄、社会经济地位、地理位置和保险可及性等差异如何影响肺癌筛查与治疗。尽管筛查、结节项目及免疫和靶向治疗取得进展,弱势患者仍难以获得高质量照护。文章提出通过识别相关健康社会决定因素并启动多层面干预来应对差异。

要点

  • 肺癌全程存在医疗差异,弱势患者更难获得高质量筛查与治疗。
  • 差异维度包括种族、民族、年龄、社会经济地位、地理位置和保险可及性。
  • 建议识别健康社会决定因素并采取多层面干预以改善所有肺癌患者照护。

核心结论

  • 从筛查到治疗,肺癌诊疗全程反映不平等的可及性与提供,弱势患者更难获得高质量照护。
  • 尽管肺癌照护取得巨大进展,美国及全球范围内差异持续存在。

研究设计与样本

  • 叙述性综述,探讨全国范围内影响肺癌照护的差异谱系,并在有数据时涉及全球趋势。

主要发现

  • 差异维度包括种族、民族、年龄、社会经济地位、地理位置和保险可及性。
  • 综述聚焦差异如何影响筛查工作与肺癌治疗。

临床怎么用

  • 识别相关健康社会决定因素,并启动多层面干预以改善所有肺癌患者照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

From screening to treatment, the continuum of lung cancer reflects unequal access and delivery, with more vulnerable patients less able to receive high-quality care. Despite great advances in lung cancer care (eg, screening and nodule programs to identify early-stage disease and immune-mediated and targeted therapies for advanced-stage disease), disparities persist both in the United States and globally. In this narrative review, the spectrum of disparities that influence lung cancer care on a national scale, including race, ethnicity, age, socioeconomic status, geographic location, and insurance access, are explored. The review focuses on how disparities impact screening efforts and lung cancer treatments. Where data are available, trends on a global scale are addressed. Potential solutions are offered to address recognized disparities, primarily by identifying pertinent social determinants of health and launching multipronged interventions to improve the care of all patients with lung cancer.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Bade B, Faiz SA, Tan M, et al. The Impact of Health Care Disparities on Lung Cancer Screening and Treatment. Chest. 2025. PMID: 40350147. doi:10.1016/j.chest.2025.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。